David G. Standaert - Concepedia

Author

David G. Standaert

University of Alabama at Birmingham ORCID

Also Known As

Andrew Singleton, Chelsea Caspell-Garcia, D G Standaert, D STANDAERT, D Standaert, D. G. Standaert, D. Standaert, D.G Standaert, D.G. Standaert, DAVID G. STANDAERT

445

Publications

32.1K

Citations

H-Index

230

Concepts

All Affiliations

University of Alabama at Birmingham Massachusetts General Hospital Harvard University MaineGeneral Medical Center Emory University

About

David G. Standaert is an author at University of Alabama at Birmingham specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	65	120	15K
2	Health Sciences	17	17	2.5K
3	Natural Sciences	6	6	520
4	Engineering	4	4	192
5	Education	1	1	12

David G. Standaert

212

Publications

24.2K

Citations

H-Index

Page 1

	Year	Citations
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial Robert G. Holloway, Ira Shoulson, Karl Kieburtz, JAMA Initial TreatmentParkinson DiseaseMedicineNeuropharmacologyPramipexole Vs Levodopa	2000	802
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease Anthone W. Dunah, Hyunkyung Jeong, April M. Griffin, Science Knockout MouseTranscriptional RegulationNeurodegenerative DiseasesSystems BiologyHd Pathogenesis	2002	702
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study C. Warren Olanow, Karl Kieburtz, Per Odin, The Lancet Neurology Advanced ParkinsonContinuous Intrajejunal InfusionNeurologyLevodopa-carbidopa Intestinal GelMedicine	2013	683
Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors Shyamal Patel, Konrad Lorincz, R. Hughes, IEEE Transactions on Information Technology in Biomedicine Wearable SystemAccelerometerWearable TechnologyDiagnosisMotor Control	2009	607
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. Jiang‐Fan Chen, Zhihong Huang, Jianya Ma, PubMed Transient Focal IschemiaSocial SciencesCerebral Vascular RegulationMolecular PharmacologyAdenosine Receptor Deficiency	1999	531
Lighting up the Senses: FM1-43 Loading of Sensory Cells through Nonselective Ion Channels Jason R. Meyers, Richard B. MacDonald, Anne Duggan, Journal of Neuroscience NeurotransmitterFm1-43 LoadingNeurotransmissionCellular PhysiologySocial Sciences	2003	527
Molecular markers of early Parkinson's disease based on gene expression in blood Clemens R. Scherzer, Aron C. Eklund, Lee Jae Morse, Proceedings of the National Academy of Sciences	2007	513
A<sub>2A</sub>Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice Jiang‐Fan Chen, Zhihong Huang, Jianya Ma, Journal of Neuroscience Transient Focal IschemiaSocial SciencesCerebral Vascular RegulationMolecular PharmacologyExtracellular Adenosine	1999	470
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses Mark S. Moehle, Philip J. Webber, Tonia E. Tse, Journal of Neuroscience ImmunologyImmune RegulationInnate ImmunityImmune SystemNeuroinflammation	2012	463
MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration Ashley S. Harms, Shuwen Cao, Amber L. Rowse, Journal of Neuroscience ImmunologyImmune RegulationImmunodominance-Synuclein-induced ActivationMhcii Complex	2013	415

Page 1